Cancer Immunotherapy in Older Patients.

  title={Cancer Immunotherapy in Older Patients.},
  author={Kristen A. Marrone and Patrick M. Forde},
  journal={Cancer journal},
  volume={23 4},
Advancing age remains one of the most significant risk factors for cancer development. Changes in the immune system occur with aging, and likely play a role in the increased incidence of malignancy in older patients. With the advent of immune checkpoint inhibitors, and their use in a variety of malignancies, there has been an explosion of clinical trials evaluating their use. Unfortunately, these trials have not shown consistent results in elderly patients, nor have age-specific outcomes been… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 1 time. VIEW TWEETS

From This Paper

Figures, tables, and topics from this paper.

Explore Further: Topics Discussed in This Paper


Publications referenced by this paper.
Showing 1-10 of 54 references

The Role of Immunosenescence in the Development of Age-Related Diseases.

Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion • 2016
View 1 Excerpt

Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer

NA Rizvi, HellmannMD, A Snyder
Science • 2015
View 1 Excerpt

Similar Papers

Loading similar papers…